|Bid||5.13 x 0|
|Ask||5.14 x 0|
|Day's range||5.09 - 5.49|
|52-week range||5.04 - 24.10|
|Beta (5Y monthly)||3.06|
|PE ratio (TTM)||N/A|
|Earnings date||09 Feb 2022 - 14 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||7.49|
On yet another "red" day for stock markets, marijuana investors saw their stocks tumble right along with the rest of the Nasdaq. In a press release early this morning, Hexo gave investors an update on its strategic plan entitled "The Path Forward," explaining how Hexo -- shares of which traded above $30 just a couple of years ago, but now fetch just $0.50 -- intends to regain its mojo and get its share price moving higher once again. New product launches appear key to Hexo's plan, as the company launches sales of a "transdermal cream and a CBD-forward body lotion," and also a new line of "gummy confection called Redebles."
While the U.S. pot growers had an amazing 2021, dark clouds loomed over their Canadian counterparts.
Select analysts and investment banks see "high" return potential for these cannabis stocks.